Incompatibilities: This medicinal product must not be mixed with other medicinal products.
Special precautions for disposal and other handling: Parenteral medicinal products such as Idarucizumab (Praxbind) should be inspected visually for particulate matter and discoloration prior to administration.
Idarucizumab (Praxbind) must not be mixed with other medicinal products. A pre-existing intravenous line may be used for administration of Idarucizumab (Praxbind). The line must be flushed with sodium chloride 9 mg/ml (0.9 %) solution for injection prior to and at the end of infusion. No other infusion should be administered in parallel via the same intravenous access.
Idarucizumab (Praxbind) is for single-use only and does not contain preservatives.
No incompatibilities between Idarucizumab (Praxbind) and polyvinyl chloride, polyethylene or polyurethane infusion sets or polypropylene syringes have been observed.
Other Services
Country
Account
Sign Out